SCHEMBL2133471

SCHEMBL2133471

C=CCCC(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3123520 0.87 MAPT (0.38)
SCHEMBL16629081 0.87 MAPT (0.38)
SCHEMBL8259830 0.87 MAPT (0.38)
SCHEMBL3115628 0.85 ALDH1A1 (0.41)
SCHEMBL3124070 0.84 ALDH1A1 (0.44)
SCHEMBL3111810 0.84 ALDH1A1 (0.44)
SCHEMBL3120484 0.84 ALDH1A1 (0.44)
SCHEMBL3116666 0.81
SCHEMBL11852334 0.81 TSHR (0.37)
SCHEMBL8048065 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077683-A1 ANTIDEPRESSANT THERAPY ALZA CORPORATION (US) 2001-02-28 EP claimed
WO-1999058115-A1 ANTIDEPRESSANT THERAPY ALZA CORPORATION (US) 1999-11-18 WO claimed
WO-2025049555-A1 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL OERTH BIO LLC (US) 2025-03-06 WO disclosed
EP-4317222-A1 (METH)ACRYLIC ACID ESTER-BASED COPOLYMER AND CURABLE COMPOSITION Kaneka Corporation (JP) 2024-02-07 EP disclosed
CN-107614568-B Fluoropolymer resin with formula 1 or formula 2, the then film containing it and the display device that is connected by then film 三星SDI株式会社 2019-06-11 CN disclosed
CN-107614568-A Macromolecule resin with chemical formula 1 or chemical formula 2, the then film containing it and the display device connected by then film 三星SDI株式会社 2018-01-19 CN disclosed
WO-2017193326-A1 DEGRADABLE VINYLPYRROLIDONE HOMOPOLYMERS AND COPOLYMERS AND METHODS FOR PREPARING THE SAME BOAI NKY PHARMACEUTICALS LTD. (CN) 2017-11-16 WO disclosed
US-20150191607-A1 Anti-fouling Paints and Coatings REACTIVE SURFACES, LTD (US) 2015-07-09 US disclosed
US-20140196631-A1 VISUAL ASSAYS FOR COATINGS INCORPORATING BIOACTIVE ENZYMES FOR CATALYTIC FUNCTIONS REACTIVE SURFACE, LTD. (US) 2014-07-17 US disclosed
EP-2550285-A1 TRIOXACARCINS AND USES THEREOF President and Fellows of Harvard College (US) 2013-01-30 EP disclosed
US-20120097194-A1 Polymeric Coatings Incorporating Bioactive Enzymes for Catalytic Function REACTIVE SURFACES, LTD. (US) 2012-04-26 US disclosed
WO-2007018376-A1 PRODUCING METHOD FOR CERIUM-BASED GLASS POLISHING MATERIAL AND METHOD FOR USING THE SAME JOUNG IN (KR) 2007-02-15 WO disclosed
EP-1734061-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof MITSUI CHEMICALS, INC. (JP) 2006-12-20 EP disclosed
US-20040122192-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. 2004-06-24 US disclosed
EP-1368352-A1 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS Pfizer Limited (GB) 2003-12-10 EP disclosed
US-20020156207-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2002-10-24 US disclosed
WO-2002074774-A1 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS PFIZER LIMITED (GB) 2002-09-26 WO disclosed
EP-1186619-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof Mitsui Chemicals, Inc. (JP) 2002-03-13 EP disclosed
EP-1077683-A1 ANTIDEPRESSANT THERAPY ALZA CORPORATION (US) 2001-02-28 EP disclosed
WO-1999058115-A1 ANTIDEPRESSANT THERAPY ALZA CORPORATION (US) 1999-11-18 WO disclosed